APA (7th ed.) Citation

Le, M., Khoury, L., Lu, Y., Prosty, C., Cormier, M., Cheng, M. P., . . . Netchiporouk, E. (2024). COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial. Open Forum Infectious Diseases, 11(4), 1. https://doi.org/10.1093/ofid/ofae102

Chicago Style (17th ed.) Citation

Le, Michelle, et al. "COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial." Open Forum Infectious Diseases 11, no. 4 (2024): 1. https://doi.org/10.1093/ofid/ofae102.

MLA (9th ed.) Citation

Le, Michelle, et al. "COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial." Open Forum Infectious Diseases, vol. 11, no. 4, 2024, p. 1, https://doi.org/10.1093/ofid/ofae102.